<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H22EBCCD0AB3E46409B91488D947F0E1C" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 5216 IH: Opioid and Heroin Abuse Crisis Investment Act of 2016</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2016-05-12</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>114th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 5216</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20160512">May 12, 2016</action-date>
			<action-desc><sponsor name-id="L000570">Mr. Ben Ray Luján of New Mexico</sponsor> (for himself, <cosponsor name-id="C000984">Mr. Cummings</cosponsor>, <cosponsor name-id="R000486">Ms. Roybal-Allard</cosponsor>, <cosponsor name-id="K000379">Mr. Kennedy</cosponsor>, <cosponsor name-id="K000381">Mr. Kilmer</cosponsor>, <cosponsor name-id="K000382">Ms. Kuster</cosponsor>, <cosponsor name-id="H000324">Mr. Hastings</cosponsor>, <cosponsor name-id="N000179">Mrs. Napolitano</cosponsor>, <cosponsor name-id="T000469">Mr. Tonko</cosponsor>, <cosponsor name-id="M001163">Ms. Matsui</cosponsor>, <cosponsor name-id="N000015">Mr. Neal</cosponsor>, <cosponsor name-id="G000556">Mr. Grayson</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="K000375">Mr. Keating</cosponsor>, <cosponsor name-id="L000580">Ms. Michelle Lujan Grisham of New Mexico</cosponsor>, <cosponsor name-id="B000574">Mr. Blumenauer</cosponsor>, <cosponsor name-id="L000263">Mr. Levin</cosponsor>, <cosponsor name-id="C001049">Mr. Clay</cosponsor>, <cosponsor name-id="L000560">Mr. Larsen of Washington</cosponsor>, <cosponsor name-id="E000290">Ms. Edwards</cosponsor>, <cosponsor name-id="K000009">Ms. Kaptur</cosponsor>, <cosponsor name-id="J000032">Ms. Jackson Lee</cosponsor>, <cosponsor name-id="C001036">Mrs. Capps</cosponsor>, <cosponsor name-id="L000562">Mr. Lynch</cosponsor>, <cosponsor name-id="N000188">Mr. Norcross</cosponsor>, <cosponsor name-id="L000581">Mrs. Lawrence</cosponsor>, <cosponsor name-id="M001137">Mr. Meeks</cosponsor>, <cosponsor name-id="M001185">Mr. Sean Patrick Maloney of New York</cosponsor>, <cosponsor name-id="S001175">Ms. Speier</cosponsor>, <cosponsor name-id="Q000023">Mr. Quigley</cosponsor>, <cosponsor name-id="G000535">Mr. Gutiérrez</cosponsor>, <cosponsor name-id="W000800">Mr. Welch</cosponsor>, <cosponsor name-id="R000576">Mr. Ruppersberger</cosponsor>, <cosponsor name-id="C001078">Mr. Connolly</cosponsor>, <cosponsor name-id="M000312">Mr. McGovern</cosponsor>, <cosponsor name-id="L000565">Mr. Loebsack</cosponsor>, <cosponsor name-id="S001168">Mr. Sarbanes</cosponsor>, <cosponsor name-id="B000911">Ms. Brown of Florida</cosponsor>, <cosponsor name-id="D000624">Mrs. Dingell</cosponsor>, <cosponsor name-id="K000188">Mr. Kind</cosponsor>, <cosponsor name-id="I000057">Mr. Israel</cosponsor>, <cosponsor name-id="P000096">Mr. Pascrell</cosponsor>, <cosponsor name-id="G000574">Mr. Gallego</cosponsor>, <cosponsor name-id="C001037">Mr. Capuano</cosponsor>, <cosponsor name-id="C001069">Mr. Courtney</cosponsor>, <cosponsor name-id="B001292">Mr. Beyer</cosponsor>, <cosponsor name-id="T000193">Mr. Thompson of Mississippi</cosponsor>, <cosponsor name-id="J000294">Mr. Jeffries</cosponsor>, <cosponsor name-id="Y000062">Mr. Yarmuth</cosponsor>, <cosponsor name-id="C001097">Mr. Cárdenas</cosponsor>, <cosponsor name-id="S001165">Mr. Sires</cosponsor>, <cosponsor name-id="K000380">Mr. Kildee</cosponsor>, <cosponsor name-id="E000215">Ms. Eshoo</cosponsor>, <cosponsor name-id="G000410">Mr. Gene Green of Texas</cosponsor>, <cosponsor name-id="V000130">Mr. Vargas</cosponsor>, <cosponsor name-id="B001270">Ms. Bass</cosponsor>, <cosponsor name-id="C001067">Ms. Clarke of New York</cosponsor>, <cosponsor name-id="V000128">Mr. Van Hollen</cosponsor>, <cosponsor name-id="C001101">Ms. Clark of Massachusetts</cosponsor>, <cosponsor name-id="C001068">Mr. Cohen</cosponsor>, <cosponsor name-id="T000465">Ms. Tsongas</cosponsor>, <cosponsor name-id="F000455">Ms. Fudge</cosponsor>, <cosponsor name-id="A000371">Mr. Aguilar</cosponsor>, <cosponsor name-id="L000582">Mr. Ted Lieu of California</cosponsor>, <cosponsor name-id="R000588">Mr. Richmond</cosponsor>, <cosponsor name-id="S001193">Mr. Swalwell of California</cosponsor>, <cosponsor name-id="L000287">Mr. Lewis</cosponsor>, <cosponsor name-id="H001064">Mr. Heck of Washington</cosponsor>, <cosponsor name-id="M001143">Ms. McCollum</cosponsor>, <cosponsor name-id="D000622">Ms. Duckworth</cosponsor>, <cosponsor name-id="J000288">Mr. Johnson of Georgia</cosponsor>, <cosponsor name-id="R000577">Mr. Ryan of Ohio</cosponsor>, <cosponsor name-id="D000620">Mr. Delaney</cosponsor>, <cosponsor name-id="E000293">Ms. Esty</cosponsor>, <cosponsor name-id="C000714">Mr. Conyers</cosponsor>, <cosponsor name-id="D000191">Mr. DeFazio</cosponsor>, <cosponsor name-id="G000553">Mr. Al Green of Texas</cosponsor>, <cosponsor name-id="L000557">Mr. Larson of Connecticut</cosponsor>, <cosponsor name-id="B001251">Mr. Butterfield</cosponsor>, <cosponsor name-id="D000096">Mr. Danny K. Davis of Illinois</cosponsor>, <cosponsor name-id="P000610">Ms. Plaskett</cosponsor>, <cosponsor name-id="L000551">Ms. Lee</cosponsor>, <cosponsor name-id="S000030">Ms. Loretta Sanchez of California</cosponsor>, <cosponsor name-id="B001296">Mr. Brendan F. Boyle of Pennsylvania</cosponsor>, <cosponsor name-id="R000599">Mr. Ruiz</cosponsor>, <cosponsor name-id="T000468">Ms. Titus</cosponsor>, <cosponsor name-id="B001285">Ms. Brownley of California</cosponsor>, <cosponsor name-id="M001196">Mr. Moulton</cosponsor>, <cosponsor name-id="D000216">Ms. DeLauro</cosponsor>, <cosponsor name-id="H001034">Mr. Honda</cosponsor>, and <cosponsor name-id="P000258">Mr. Peterson</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committees on the <committee-name committee-id="HJU00">Judiciary</committee-name> and <committee-name committee-id="HBU00">the Budget</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To provide funding for opioid and heroin abuse prevention and treatment, and for other purposes.</official-title>
	</form>
	<legis-body id="H1853FDDAE34848BAABBF2F890EB3CA27" style="OLC">
 <section id="H86A847EE4B1646FFA0105382949CD659" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Opioid and Heroin Abuse Crisis Investment Act of 2016</short-title></quote>.</text> </section><section id="HF95F865D46324AA3B9468865042313BB" section-type="subsequent-section"><enum>2.</enum><header>Funding for opioid and heroin abuse prevention and treatment</header> <subsection commented="no" display-inline="no-display-inline" id="H79D0E128876A41CDB4A1E70AE9CEFDF7"><enum>(a)</enum><header display-inline="yes-display-inline">Funding</header><text display-inline="yes-display-inline">There are authorized to be appropriated, and are appropriated, out of monies in the Treasury not otherwise obligated, $1,164,600,000 for the period of fiscal years 2017 and 2018, to improve opioid prescribing practices and expand access to substance use treatment and to reduce opioid use disorders and overdose, to be made available in accordance with this Act and the amendments made by this Act.</text>
 </subsection><subsection commented="no" display-inline="no-display-inline" id="HE7EA3CE4C61D4D7EA9715EA6B6426542"><enum>(b)</enum><header>State targeted response cooperative agreements</header><text>Subpart 1 of part B of title V of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290bb">42 U.S.C. 290bb et seq.</external-xref>) is amended by inserting after section 509 the following:</text>
				<quoted-block display-inline="no-display-inline" id="H713FAC40BC0545E18BAE2A9C3E74505F" style="OLC">
					<section commented="no" display-inline="no-display-inline" id="HF81748AD9C1348D8A5AD8AAEF2FB5F22"><enum>510.</enum><header>State targeted response cooperative agreements</header>
 <subsection commented="no" display-inline="no-display-inline" id="HB9218F91EA8542A1A49BF085A9203979"><enum>(a)</enum><header>In general</header><text>The Secretary shall enter into additional targeted response cooperative agreements with States under this title to expand opioid treatment capacity and make services more affordable to those who cannot afford such services.</text>
 </subsection><subsection commented="no" display-inline="no-display-inline" id="H63B780C043254D6EB051543126EEA1F6"><enum>(b)</enum><header>Awarding of funding</header><text>The Secretary shall allocate funding to States under this section based on—</text> <paragraph commented="no" display-inline="no-display-inline" id="H2E7B4EBD26904EF8AED70E411850BD0B"><enum>(1)</enum><text>the severity of the opioid epidemic in the State; and</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="H6A32F8370DA54EE9B9AABE6B66D46811"><enum>(2)</enum><text>the strength of the strategy of the State to respond to such epidemic.</text> </paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="H96508065D5ED4AB2AF6755BEB71AD207"><enum>(c)</enum><header>Use of funds</header><text>Amounts received by a State under this section shall be used to expand treatment capacity and make services more affordable to those who cannot afford such services and to help individuals seek treatment, successfully complete treatment, and sustain recovery.</text>
 </subsection><subsection commented="no" display-inline="no-display-inline" id="H853B7FC2A4224E488DDF2AF778BD91AB"><enum>(d)</enum><header>Funding</header><text>From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $465,000,000 is available to carry out this section for each of fiscal years 2017 and 2018.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block> </subsection><subsection commented="no" display-inline="no-display-inline" id="HDD748A5A916345F4B6979926FE1F1E74"><enum>(c)</enum><header>Treatment for prescription drug abuse and heroin use</header><text>Section 331(b) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/254d">42 U.S.C. 254d(b)</external-xref>) is amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="H86E6CB718B2049DD9BF90662B2E4FD66" style="OLC">
 <paragraph id="id999558FB8DCF48178D388E634C775D00" indent="up1"><enum>(3)</enum><subparagraph commented="no" display-inline="yes-display-inline" id="id835E0CED5E6E4FEEBA612EF9B65C8521"><enum>(A)</enum><text>The Secretary shall use amounts made available under subparagraph (B) to support enhanced loan repayment awards to increase the number of clinicians in the Corps with medication-assisted treatment training to treat individuals with opioid use disorders through loan repayments to clinicians.</text>
 </subparagraph><subparagraph id="idDD379B25C37B4E48A381FA47A7EB63A1" indent="up1"><enum>(B)</enum><text>From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $25,000,000 is available to carry out this paragraph for each of fiscal years 2017 and 2018.</text> </subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block> </subsection><subsection commented="no" display-inline="no-display-inline" id="HD81E76D530644A4CB76357A8211A74C5"><enum>(d)</enum><header>Evaluation of medication-Assisted treatment</header><text>Subpart 1 of part B of title V of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290bb">42 U.S.C. 290bb et seq.</external-xref>) is amended by inserting after section 510, as added by subsection (b), the following:</text>
				<quoted-block display-inline="no-display-inline" id="HD7A8811465DE4D64911FCCD8AED673E7" style="OLC">
					<section commented="no" display-inline="no-display-inline" id="HF905B22B51254564A335504DF1136CD3"><enum>511.</enum><header>Evaluation of medication-assisted treatment</header>
 <subsection commented="no" display-inline="no-display-inline" id="H49619B4A623E44848A1A45560499D501"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">In order to assess the treatment outcomes of patients with opioid addiction receiving medication-assisted treatment, the Secretary shall evaluate the short-, medium-, and long-term outcomes of such substance abuse treatment programs in order to increase effectiveness in reducing opioid use disorders, overdose, and death.</text>
 </subsection><subsection commented="no" display-inline="no-display-inline" id="H6CACF6871FB3465BBD7261847D89CB98"><enum>(b)</enum><header display-inline="yes-display-inline">Funding</header><text display-inline="yes-display-inline">From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $15,000,000 is available to carry out this section for each of fiscal years 2017 and 2018.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block> </subsection><subsection commented="no" display-inline="no-display-inline" id="H0343FB73025243759DE41788821FB600"><enum>(e)</enum><header>Medication-Assisted treatment for prescription drug and opioid addiction</header><text>Section 509 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290bb-2">42 U.S.C. 290bb–2</external-xref>) is amended—</text>
 <paragraph commented="no" display-inline="no-display-inline" id="H8FDA6814194940D3A915055DE5711A01"><enum>(1)</enum><text>by redesignating subsection (f) as subsection (g); and</text> </paragraph><paragraph commented="no" display-inline="no-display-inline" id="HB1A37C06F7854D5399E837E08124CAE5"><enum>(2)</enum><text>by inserting after subsection (e), the following:</text>
					<quoted-block display-inline="no-display-inline" id="H51E24D20DBB4406D9AEBFFA4C53D7725" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="H551D87CE9896490889AE950DB417FCC8"><enum>(f)</enum><header>Medication-Assisted treatment for prescription drug and opioid addiction</header>
 <paragraph commented="no" display-inline="no-display-inline" id="H7589236CDFD74BAF9B605D0478A74EB6"><enum>(1)</enum><header>In general</header><text>In carrying out this section, the Secretary shall use amounts made available under paragraph (3) to award grants to States to expand or enhance medication-assisted treatment utilizing medications approved by the Food and Drug Administration in combination with psychosocial services, recovery support services, and coordination with HIV or hepatitis C direct services.</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="H9DD6B258DB0241B0A0CC7915E612F7F4"><enum>(2)</enum><header display-inline="yes-display-inline">Funding</header><text display-inline="yes-display-inline">From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $50,100,000 is available to carry out this subsection for fiscal year 2017.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block> </paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="H6EA98025DC544A68ACEAEE5CED61D670"><enum>(f)</enum><header>Dissemination of guidelines for preventing prescription drug overdose</header><text>Section 317 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b">42 U.S.C. 247b</external-xref>) is amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="H4BAB1C22C3554D0BA63721F1F7B07F56" style="OLC">
					<subsection commented="no" display-inline="no-display-inline" id="H3DDF453C23D7471D8410E3F4ED1950B0"><enum>(n)</enum><header>Dissemination of guidelines for preventing prescription drug overdose</header>
 <paragraph commented="no" display-inline="no-display-inline" id="H71C610888E5E4311AF39BCE6B417D1A9"><enum>(1)</enum><header>In general</header><text>The Director of the Centers for Disease Control and Prevention shall disseminate guidelines to improve opioid prescribing practices to reduce opioid use disorders and overdose.</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="H4367CFF7F7314292991D126814DDB2A6"><enum>(2)</enum><header>Use of funds</header><text>In carrying out this subsection, the Director of the Centers for Disease Control and Prevention shall use amounts made available under paragraph (3) to—</text>
 <subparagraph commented="no" display-inline="no-display-inline" id="HFA13884BDFF94D409F1E1E9A46F8B410"><enum>(A)</enum><text>pilot test, evaluate, and adapt comprehensive tools and dissemination strategies to convey opioid prescribing guidelines of the Centers for Disease Control and Prevention in succinct, usable formats accessible to health care providers;</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="HB212B075B27B4578A84182F367D86702"><enum>(B)</enum><text>develop, evaluate, and publicly disseminate clinical decision support tools derived from the opioid prescribing guidelines of the Centers for Disease Control and Prevention;</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="H725B770ACEDE44068B7684EFC8DA82C7"><enum>(C)</enum><text>establish training modules in partnership with professional societies and health systems, including online modules available for continuing medical education credits and maintenance of certification; and</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="H3518FF2EAC1D49E8A4BCFA4195FC716C"><enum>(D)</enum><text>coordinate with Office of the National Coordinator for Health Information Technology to ensure that guidelines developed under this subsection are effectively disseminated and translated into clinical support tools for integration into clinical workflow.</text>
 </subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="HE7CB83267B744536BE013A23866F78A2"><enum>(3)</enum><header display-inline="yes-display-inline">Funding</header><text display-inline="yes-display-inline">From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $10,000,000 is available to carry out this subsection for fiscal year 2017.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block> </subsection><subsection commented="no" display-inline="no-display-inline" id="H65FDC0D0410844E3ABFB6FCAC1DC5192"><enum>(g)</enum><header>Rural opioid overdose reversal grant program</header><text>Section 330A of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/254c">42 U.S.C. 254c</external-xref>) is amended—</text>
 <paragraph commented="no" display-inline="no-display-inline" id="HB572E09913C54CB0BECE72A25833B0A1"><enum>(1)</enum><text>by redesignating subsection (j) as subsection (k); and</text> </paragraph><paragraph commented="no" display-inline="no-display-inline" id="H7EAA4AEBBA3F41BFB2FCE9FAA10DC57F"><enum>(2)</enum><text>by inserting after subsection (i), the following:</text>
					<quoted-block display-inline="no-display-inline" id="H3A67BEDAD86043D096BCBE8FD106BBB0" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="H186D153554F849EDA9F439E3023FA026"><enum>(j)</enum><header>Rural opioid overdose reversal grant program</header>
 <paragraph commented="no" display-inline="no-display-inline" id="H97C390D5F45B44F48DDC7952BED943DB"><enum>(1)</enum><header>In general</header><text>The Director may award grants to eligible entities to implement activities for the prevention, intervention, and treatment of opioid misuse and overdose.</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="H96060DD938354620B244B20E0B5F03E8"><enum>(2)</enum><header display-inline="yes-display-inline">Eligibility</header><text display-inline="yes-display-inline">To be eligible to receive a grant under this subsection, an entity—</text> <subparagraph commented="no" display-inline="no-display-inline" id="HBD1008E661F6474AB9A88AA7F823D75B"><enum>(A)</enum><text>shall be a rural public or rural nonprofit private entity; and</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="HBFCCDF16BC004C8596EDFF1103F97D00"><enum>(B)</enum><text>shall represent a network composed of participants—</text> <clause id="H64729A58635C4BBF8DA9D533A2B4004A"><enum>(i)</enum><text>that include 3 or more health care providers; and</text>
 </clause><clause id="H35311E70DC834A86A12546D9541B51FA"><enum>(ii)</enum><text>that may be nonprofit or for-profit entities.</text> </clause></subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="H3CAEAA8581344214AE0E82C66B029E90"><enum>(3)</enum><header>Use of funds</header><text>Amounts awarded under a grant under this subsection shall be used—</text>
 <subparagraph id="HF68EB9F4D658491281B38E3529A5E773"><enum>(A)</enum><text>to provide opioid misuse education and prevention services;</text> </subparagraph><subparagraph id="H52C665C255F04DA2A3C0D9CB0F82002C"><enum>(B)</enum><text>to provide training to licensed health care professionals and first responders in the recognition of the signs of opioid overdose and learn the appropriate way to administer naloxone;</text>
 </subparagraph><subparagraph id="H41037B0B13504093ABEBEF8B5FAD46F8"><enum>(C)</enum><text>to provide appropriate transportation services to a hospital or clinic for continued care after administration;</text>
 </subparagraph><subparagraph id="HB3E7BA8BE6884F9ABF1544596E8F24E4"><enum>(D)</enum><text>to refer those individuals with a drug dependency to an appropriate substance use disorder treatment centers where care coordination is provided by a team of providers; and</text>
 </subparagraph><subparagraph id="HE02FD983DD0145B58305E25A5C342261"><enum>(E)</enum><text>to purchase naloxone and opioid overdose reversal devices.</text> </subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="H27875DBE1D414FECB952B90BAD6056CA"><enum>(4)</enum><header display-inline="yes-display-inline">Funding</header><text display-inline="yes-display-inline">From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $10,000,000 is available to carry out this subsection for fiscal year 2017.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
 </paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="HCE598575F81441BA8C676B3D798C046F"><enum>(h)</enum><header>Prescription drug overdose initiative</header><text>Section 3001(c) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300jj-11">42 U.S.C. 300jj–11(c)</external-xref>) is amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="H737AE12062EA41AEA286DA25015271FC" style="OLC">
					<paragraph commented="no" display-inline="no-display-inline" id="HF36B3C7765DE4AC19272547345536E19"><enum>(9)</enum><header>Prescription drug overdose initiative</header>
 <subparagraph commented="no" display-inline="no-display-inline" id="H37E49420BE4F44E1A4C80448C16AE348"><enum>(A)</enum><header>In general</header><text>The Secretary, acting through the National Coordinator, shall use amounts made available under subparagraph (B) to expand efforts to harmonize technical standards to support prescription drug monitoring programs and health information technology interoperability.</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="HA74293A63DB54B618353E236CBD7DBA7"><enum>(B)</enum><header display-inline="yes-display-inline">Funding</header><text display-inline="yes-display-inline">From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $5,000,000 is available to carry out this paragraph for fiscal year 2017.</text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block> </subsection><subsection commented="no" display-inline="no-display-inline" id="H6F78BA7703DF4485B33906119C08E1BE"><enum>(i)</enum><header>Bureau of Prisons treatment programs</header><text>Section 4042 of title 18, United States Code, is amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="HF4695268C3AB40A3BF34F5DBFB03EB29" style="OLC">
					<subsection commented="no" display-inline="no-display-inline" id="H8184EE915BEF4D478612213B7EFDBB9D"><enum>(e)</enum><header>Treatment programs</header>
 <paragraph commented="no" display-inline="no-display-inline" id="HF14148E2309F4D6B9F3E0AC6F189E0F9"><enum>(1)</enum><header>In general</header><text>The Director of the Bureau of Prisons shall use amounts made available under paragraph (2) to support drug treatment programs within the Bureau of Prisons, including expanding the medication-assisted treatment pilot.</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="H4867D013878A4783BC300634CDEB6FB4"><enum>(2)</enum><header display-inline="yes-display-inline">Funding</header><text display-inline="yes-display-inline">From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $3,000,000 is available to carry out this subsection for fiscal year 2017.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block> </subsection><subsection commented="no" display-inline="no-display-inline" id="H4A9D88E39EAE4443BCFE5B4BAD87D08C"><enum>(j)</enum><header>Second Chance Act of 2007</header><text>Section 201 of the Second Chance Act of 2007 (<external-xref legal-doc="usc" parsable-cite="usc/42/17521">42 U.S.C. 17521</external-xref>) is amended—</text>
 <paragraph commented="no" display-inline="no-display-inline" id="H2D41003C3DE24F1898E91B98202BA163"><enum>(1)</enum><text>by redesignating subsection (f) as subsection (g); and</text> </paragraph><paragraph commented="no" display-inline="no-display-inline" id="H8EF048F3903B428082012BD4586E418F"><enum>(2)</enum><text>by inserting after subsection (e), the following:</text>
					<quoted-block display-inline="no-display-inline" id="HCC0601C35C284AD0A4EBC9BD5A36C57F" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="H0A126A1E52E14F3B889F7D31B6F1AF21"><enum>(f)</enum><header>Community reintegration</header>
 <paragraph commented="no" display-inline="no-display-inline" id="H16E64859C3E44C4C9C1CD95E767F0E92"><enum>(1)</enum><header>In general</header><text>The Attorney General shall use amounts made available under paragraph (2) to carry out activities to reduce recidivism and increase public safety by helping justice-involved individuals successfully reintegrate into the community, including by carrying out activities including providing treatment for co-occurring disorders and providing family-based substance abuse treatment.</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="H07AEEFF49D60417588C5A0A388D4CA22"><enum>(2)</enum><header display-inline="yes-display-inline">Funding</header><text display-inline="yes-display-inline">From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $50,000,000 is available to carry out this subsection for fiscal year 2017.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block> </paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="HA9BA580A7A8B4D2B96DB8E9DD1B2345C"><enum>(k)</enum><header>Residential substance abuse treatment</header><text>Section 503 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/873">21 U.S.C. 873</external-xref>) is amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="HD4640B7F0CF54629A6F3AFCA9E4CBFC1" style="OLC">
 <subsection commented="no" display-inline="no-display-inline" id="H5D60B3AD8F3A499C9E0F358D5BA7C4AA"><enum>(e)</enum><paragraph commented="no" display-inline="yes-display-inline" id="id291927DBF69E4E18A99E9E8232EEC167"><enum>(1)</enum><text>In carrying out this section, the Attorney General may use amounts made available under paragraph (2) to provide support for State, local, and tribal governments in the development of residential and aftercare services for substance-involved inmates.</text>
 </paragraph><paragraph id="idB92508FC796E4F31BE198836172AEBFC" indent="up1"><enum>(2)</enum><text>From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $14,000,000 is available to carry out this section for fiscal year 2017.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block> </subsection><subsection commented="no" display-inline="no-display-inline" id="H2F0821995B6E454F9137FBFD4770AA2F"><enum>(l)</enum><header>Heroin enforcement groups</header><text>Part E of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/871">21 U.S.C. 871 et seq.</external-xref>) is amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="H212B311A14A4472CA610768D0C14FCA9" style="OLC">
					<section commented="no" display-inline="no-display-inline" id="HE714DDC9A7E8495DAF42FFA644D316EE"><enum>521.</enum><header>Heroin enforcement groups</header>
 <subsection commented="no" display-inline="no-display-inline" id="HA5E2A72B40B64E5D8334412C372C39EB"><enum>(a)</enum><header>In general</header><text>The Attorney General shall use amounts made available under subsection (b) to establish new heroin enforcement groups within the Drug Enforcement Administration to target, disrupt, and dismantle heroin trafficking organizations.</text>
 </subsection><subsection commented="no" display-inline="no-display-inline" id="H233A5DA43B3145B3B32559C6123370A3"><enum>(b)</enum><header display-inline="yes-display-inline">Funding</header><text display-inline="yes-display-inline">From amounts appropriated under section 2(a) of the <short-title>Opioid and Heroin Abuse Crisis Investment Act</short-title>, $12,500,000 is available to carry out this section for fiscal year 2017.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block> </subsection><subsection id="H3AF2F65F361B4639BFF7295FEFDD78B6"><enum>(m)</enum><header>Emergency designation</header><text display-inline="yes-display-inline">The amounts made available by this Act are designated as an emergency requirement pursuant to section 4(g) of the Statutory Pay-As-You-Go Act of 2010 (<external-xref legal-doc="usc" parsable-cite="usc/2/933">2 U.S.C. 933(g)</external-xref>).</text>
			</subsection></section></legis-body>
</bill>


